TP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy.
Lee YS, Choi JY, Lee J, Shim DM, Kim J, Park WY, Nam DH, Seo SW
Tumour Biol. 2018 Aug;40(8):1010428318794217. doi: 10.1177/1010428318794217.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.